CDIO

Cardio Diagnostics Holdings Inc

Add to Watchlist

Advanced Chart

3.810

+0.02(0.528%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

3.810

Open

3.750

VWAP

3.74

Vol

6.84K

Mkt Cap

6.72M

Low

3.670

Amount

25.60K

EV/EBITDA(TTM)

Total Shares

22.69M

-1.21M

EV/OCF(TTM)

P/S(TTM)

3.23K

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

75.00K

+852.99%

-1.800

-0%

150.00K

+2179.64%

-1.800

-0%

250.00K

+5443.24%

-1.800

+500%

Estimates Revision

The market is revising No Change the revenue expectations for Cardio Diagnostics Holdings, Inc. (CDIO) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -9.50%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-9.50%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Cardio Diagnostics Holdings Inc (CDIO.O) is -0.55, compared to its 5-year average forward P/E of -4.32. For a more detailed relative valuation and DCF analysis to assess Cardio Diagnostics Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-4.32

Current PE

-0.55

Overvalued PE

1.28

Undervalued PE

-9.91

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

99.07

Current PS

12.58

Overvalued PS

291.34

Undervalued PS

-93.20

Financials

Annual

Quarterly

FY2025Q2

YoY :

-5.02%

7.48K

Total Revenue

FY2025Q2

YoY :

+30.90%

-1.68M

Operating Profit

FY2025Q2

YoY :

+30.68%

-1.68M

Net Income after Tax

FY2025Q2

YoY :

-43.27%

-0.97

EPS - Diluted

FY2025Q2

YoY :

+13.87%

-1.61M

Free Cash Flow

FY2025Q2

YoY :

0.00%

100.00

Gross Profit Margin - %

FY2025Q2

YoY :

+37.59%

-22.52K

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

49.8K

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

49.8K

USD

Months

CDIO News & Events

Events Timeline

2025-07-22 (ET)

2025-07-22

09:13:48

Cardio Diagnostics gets CMS gapfill payment rates for cardiovascular tests

2025-07-08 (ET)

2025-07-08

09:17:19

Cardio Diagnostics, AGEPHA Pharma in deal for heart disease study

2025-06-10 (ET)

2025-06-10

08:56:06

Cardio Diagnostics secures Japanese patent for set of biomarkers

News

8.0

07-22Newsfilter

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

7.5

07-08Newsfilter

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

3.5

06-10Newsfilter

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology